Singapore Paincare Holdings Limited (SGX:FRQ)
Singapore · Delayed Price · Currency is SGD 0.1070
-0.0040 (-3.60%)
At close: Feb 26, 2026
SGXC:FRQ Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 25.81 | 25.97 | 26.91 | 22.08 | 18.84 | 10.96 |
Other Revenue | 0.81 | 1.06 | 0.58 | 0.34 | 0.35 | 0.4 |
| 26.63 | 27.03 | 27.49 | 22.42 | 19.19 | 11.35 | |
Revenue Growth (YoY) | -5.73% | -1.65% | 22.58% | 16.85% | 69.05% | 13.82% |
Cost of Revenue | 19.8 | 18.75 | 17.87 | 13.56 | 10.39 | 5.97 |
Gross Profit | 6.83 | 8.28 | 9.62 | 8.86 | 8.8 | 5.38 |
Selling, General & Admin | 0.38 | 0.43 | 0.24 | 0.21 | 1.25 | 0.11 |
Other Operating Expenses | 4.3 | 4.28 | 4.04 | 4.67 | 1.02 | 2.22 |
Operating Expenses | 7.15 | 7.28 | 6.78 | 6.76 | 3.41 | 3.06 |
Operating Income | -0.32 | 1 | 2.84 | 2.1 | 5.39 | 2.31 |
Interest Expense | -0.2 | -0.27 | -0.26 | -0.21 | -0.15 | -0.23 |
Interest & Investment Income | - | 0 | 0 | 0 | 0 | 0 |
Earnings From Equity Investments | -0.46 | -0.64 | 0.81 | 0.1 | 0.4 | 0.28 |
Other Non Operating Income (Expenses) | -0.26 | -0.22 | -0.24 | - | 0.63 | 0.23 |
EBT Excluding Unusual Items | -1.23 | -0.12 | 3.15 | 1.99 | 6.28 | 2.6 |
Impairment of Goodwill | -2.66 | -2.66 | - | - | - | - |
Gain (Loss) on Sale of Investments | -0.29 | -0.29 | - | -0.73 | -1.11 | - |
Gain (Loss) on Sale of Assets | 0.12 | 0.02 | - | - | - | - |
Asset Writedown | -0.61 | -0.61 | -0.2 | - | - | - |
Other Unusual Items | - | - | - | - | 0.04 | 0.02 |
Pretax Income | -4.66 | -3.66 | 2.95 | 1.26 | 5.21 | 2.62 |
Income Tax Expense | -0.1 | 0.08 | 0.58 | 1.29 | 0.88 | 0.46 |
Earnings From Continuing Operations | -4.57 | -3.74 | 2.38 | -0.03 | 4.33 | 2.16 |
Minority Interest in Earnings | -0.33 | -0.3 | -0.41 | -0.64 | -0.43 | 0.04 |
Net Income | -4.89 | -4.03 | 1.97 | -0.67 | 3.9 | 2.2 |
Net Income to Common | -4.89 | -4.03 | 1.97 | -0.67 | 3.9 | 2.2 |
Net Income Growth | - | - | - | - | 77.33% | 17.16% |
Shares Outstanding (Basic) | 171 | 171 | 171 | 175 | 180 | 169 |
Shares Outstanding (Diluted) | 171 | 171 | 171 | 175 | 180 | 169 |
Shares Change (YoY) | - | - | -2.31% | -2.55% | 6.01% | 112.82% |
EPS (Basic) | -0.03 | -0.02 | 0.01 | -0.00 | 0.02 | 0.01 |
EPS (Diluted) | -0.03 | -0.02 | 0.01 | -0.00 | 0.02 | 0.01 |
EPS Growth | - | - | - | - | 67.15% | -45.88% |
Free Cash Flow | 2.67 | 1.99 | 2.94 | 3.68 | 5.9 | 2.76 |
Free Cash Flow Per Share | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 |
Dividend Per Share | - | - | - | 0.004 | 0.012 | 0.007 |
Dividend Growth | - | - | - | -70.83% | 60.00% | 7.14% |
Gross Margin | 25.64% | 30.63% | 35.00% | 39.53% | 45.85% | 47.38% |
Operating Margin | -1.20% | 3.71% | 10.34% | 9.38% | 28.09% | 20.39% |
Profit Margin | -18.37% | -14.92% | 7.15% | -2.97% | 20.33% | 19.38% |
Free Cash Flow Margin | 10.01% | 7.34% | 10.70% | 16.43% | 30.75% | 24.30% |
EBITDA | -0.01 | 1.44 | 3.38 | 2.46 | 5.57 | 2.4 |
EBITDA Margin | -0.05% | 5.34% | 12.31% | 10.98% | 29.03% | 21.13% |
D&A For EBITDA | 0.31 | 0.44 | 0.54 | 0.36 | 0.18 | 0.08 |
EBIT | -0.32 | 1 | 2.84 | 2.1 | 5.39 | 2.31 |
EBIT Margin | -1.20% | 3.71% | 10.34% | 9.38% | 28.09% | 20.39% |
Effective Tax Rate | - | - | 19.48% | 102.39% | 16.95% | 17.59% |
Advertising Expenses | - | - | - | 0.03 | 1.11 | 0.06 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.